Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 86.675
-2.33 %
$ 13.7 B
Market Cap
-11.27
P/E
Price Target
Average
72.68%
Revenue Forecast
Estimate
6.71%
EBIT
Estimate
--11.34%
Net Income
Estimate
31.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Illumina, Inc.
Wall Street analysts predict an average 1-year price target for ILMN of $150 , with forecasts ranging from
a
low of
$58 to a high of $200 .
ILMN Lowest Price Target
Wall Street Target
58 USD
-33.08%
ILMN Average Price Target
Wall Street Target
150 USD
72.68%
ILMN Highest Price Target
Wall Street Target
200 USD
130.75%
REVENUE FORECAST
Revenue Forecast Chart ILMN
EBIT FORECAST
EBIT Forecast Chart ILMN
NET INCOME FORECAST
Net Income Chart ILMN